POST Online Media Lite Edition


Cesca Therapeutics adds Mark Bagnall to board

Staff writer |
Rancho Cordova, Ca., USA - June 21, 2016, Rancho Cordova, Ca., USA - Cesca Therapeutics, a regenerative medicine company, announced that Mark Bagnall has been appointed to the board of directors from July 1, 2016.

Mr. Bagnall has more than 20 years of experience in senior management positions in both public and private biotechnology companies. He is the Co-Founder of Naia Pharmaceuticals where he currently serves as Director, Chief Financial Officer and Chief Operating Officer.

Mr. Bagnall serves as Chairman of the Board of XCR Diagnostics and as a director on the Board of Directors of Ativa Medical.


What to read next

Cesca announces change in executive leadership
BriaCell Therapeutics appoints Markus Lacher as senior director
Arcadia Bio appoints Matthew Plavan as CFO